{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:48:19Z","timestamp":1648583299932},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:00:00Z","timestamp":1401148800000},"content-version":"vor","delay-in-days":146,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.resinv.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T23:00:18Z","timestamp":1386630018000},"page":"3-4","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic strategies in lymphangioleiomyomatosis (LAM)"],"prefix":"10.1016","volume":"52","author":[{"given":"Judith L.","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho","family":"Yin Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn M.","family":"Moir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2013.11.002_bib1","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm","volume":"186","author":"McCormack","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2013.11.002_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1165\/rcmb.2005-0300OC","article-title":"Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2013.11.002_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"National Institutes of Health Rare Lung Diseases Consortium, MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2013.11.002_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2013.11.002_bib5","first-page":"13","article-title":"Sirolimus decreases circulating LAM cells in patients with lymphangioleiomyomatosis","author":"Cai","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2013.11.002_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.2011.01344.x","article-title":"Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells","volume":"164","author":"Moir","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.resinv.2013.11.002_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1165\/rcmb.2009-0050OC","article-title":"Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2 \u2013 deficient lymphangioleiomyomatosis-like cells","volume":"42","author":"Lee","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2013.11.002_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S1806-37132011000400003","article-title":"Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade","volume":"37","author":"Pimenta","year":"2011","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.resinv.2013.11.002_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S1806-37132013000100002","article-title":"Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response","volume":"39","author":"Pimenta","year":"2013","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.resinv.2013.11.002_bib10","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 is required for proliferation and survival of TSC2-null cells","volume":"12","author":"Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.resinv.2013.11.002_bib11","article-title":"Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)","volume":"154","author":"Goncharova","year":"2012","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.resinv.2013.11.002_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1165\/rcmb.2013-0203RC","article-title":"Statins in lymphangioleiomyomatosis. Simvastin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling","volume":"49","author":"Atochina-Vasserman","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2013.11.002_bib13","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1111\/j.1582-4934.2012.01648.x","article-title":"Lamstatin \u2013 a novel inhibitor of lymphangiogenesis derived from collagen IV","volume":"16","author":"Weckmann","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.resinv.2013.11.002_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2012-0476OC","article-title":"Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis","volume":"49","author":"Li","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2013.11.002_bib15","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"37","author":"Gu","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451300155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451300155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T08:50:55Z","timestamp":1538988655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253451300155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S221253451300155X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2013.11.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}